This large-scale analysis suggests that OSA status may act as an effect modifier in the association between GLP-1-RA prescription and mortality. The results of this study may lead to OSA diagnosis identifying diabetes patients more likely to derive mortality benefit from GLP-1 therapythe 20% greater relative mortality reduction in patients with OSA supports considering OSA status when making GLP-1 prescribing decisions, the investigators say
Semaglutide will not cause a positive drug test result in an insurance context
Direct-to-consumer marketing by telehealth platforms and compounding pharmacies has fueled demand for compounded GLP-1 therapies, promoted as affordable and personalized alternatives
Three key insights emerge from this comprehensive analysis
"Units" measure liquid volume, not peptide mass
Upon inspection of the premises, the Ukussa team, together with the Food and Drug Inspectors who were also involved in the crackdown seized a stock of vials of Glutathione, both used and unused, valued at around Rs